Search

Search Results

• 

  Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

  Marcello Di Nisio, Matteo Candeloro, Nicola Potere, Ettore Porreca, Jeffrey I. Weitz

  16-05-2024

  https://doi.org/10.4081/btvb.2024.118

  749

  PDF: 296
• 

  Stroke in women: anticoagulation in a complicated puzzle

  Francesco Marongiu, Elvira Grandone, Silvia Marongiu, Antonella Mameli, Doris Barcellona

  26-08-2024

  https://doi.org/10.4081/btvb.2024.137

  1065

  PDF: 282
• 

  Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?

  Anna Maria Gori, Eleonora Camilleri, Alessia Bertelli, Angela Rogolino, Francesca Cesari, Elena Lotti, Tommaso Capobianco, Walther Iannotti, Betti Giusti , Rossella Marcucci

  14-12-2022

  https://doi.org/10.4081/btvb.2022.50

  785

  PDF: 305
• 

  New perspectives for prevention of the post-thrombotic syndrome

  Paolo Prandoni

  22-03-2022

  https://doi.org/10.4081/btvb.2022.20

  1438

  PDF: 440
• 

  Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

  Agnes Y.Y. Lee

  29-02-2024

  https://doi.org/10.4081/btvb.2024.111

  1441

  PDF: 306
• 

  Safety and efficacy of treatment with vitamin K antagonists in patients managed in a network of anticoagulation services or as routine general care

  Gianfranco De Girolamo, Luca Sarti, Sonia Cecoli, Karin Bonora, Chiara Ajolfi, Francesco Bellelli, Valeria Coluccio, Gualtiero Palareti, Marco Marietta

  15-04-2022

  https://doi.org/10.4081/btvb.2022.9

  638

  PDF: 210

  Supplementary Files: 68
• 

  Personalized bleeding risk assessment for atrial fibrillation patients on direct oral anticoagulants: the DOAC score

  Paolo Prandoni

  11-10-2023

  https://doi.org/10.4081/btvb.2023.97

  1479

  PDF: 220
• 

  Location of metastasis and complications in patients with venous thromboembolism and cancer: a systematic review

  Maria Barca-Hernando, Victor Garcia-Garcia, Luis Jara-Palomares

  16-05-2024

  https://doi.org/10.4081/btvb.2024.114

  476

  PDF: 176
• 

  Management of atrial fibrillation: a practical and useful synopsis of last guidelines

  Gualtiero Palareti

  24-02-2025

  https://doi.org/10.4081/btvb.2025.168

  681
• 

  Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?

  Mattia Galli, C. Michael Gibson, Dominick J. Angiolillo

  03-08-2023

  https://doi.org/10.4081/btvb.2023.90

  1353

  PDF: 453
• 

  Pathways for lower extremity superficial vein thrombosis management in an academic medical center

  Gisoo Imani, Aaron Wilson, Sara Vazquez, Daniel M. Witt

  24-03-2025

  https://doi.org/10.4081/btvb.2025.155

  165

  PDF: 34
• 

  Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)

  Daniela Poli, Walter Ageno, Emilia Antonucci, Salvatore Bradamante, Eugenio Bucherini, Paolo Chiarugi, Antonio Chistolini, Benilde Cosmi, Anna Falanga, Antonio Insana, Domenico Lione, Rosa Maria Lombardi, Giuseppe Malcangi, Rossella Marcucci, Giuliana Martini, Lucilla Masciocco, Carmelo Paparo, Daniele Pastori, Simona Pedrini, Vittorio Pengo, Pasquale Pignatelli, Andrea Toma, Sophie Testa, Gualtiero Palareti

  27-06-2023

  https://doi.org/10.4081/btvb.2023.84

  1223

  PDF: 278

  Supplementary File: 149
• 

  Evaluation of Coaguchek^®Pro II coagulation testing device performance to assess direct oral anticoagulant action. The DOAC-CHECK study

  Cristina Legnani, Michela Cini, Sophie Testa, Alberto Tosetto, Claudia Dellanoce, Stefania Bellesso, Giuseppe Carli, Ilaria Nichele, Laura Lissandrini, Serena Zorzi, Emilia Antonucci, Gualtiero Palareti

  01-12-2022

  https://doi.org/10.4081/btvb.2022.37

  1447

  PDF: 291